Does fibrinogen add to prediction of cardiovascular disease? Results from the Scottish Heart Health Extended Cohort Study

No abstract is available for this paper.

• Publication year

  2009

• Venue

  British Journal of Haematology

• Publication date

  2009-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2141.2009.07778.xPMID 19549268
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influence of Fibrinogen on Cardiovascular Disease

  2012cited by this paper
• Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond

  2008influential reference
• Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2

  2008cited by this paper
• Meta-Analysis Associations of Plasma Fibrinogen Levels with Established Cardiovascular Disease Risk Factors, Inflammatory Markers, and Other Characteristics: Individual Participant Meta-Analysis of 154,211 Adults in 31 Prospective Studies

  2007cited by this paper
• Risk estimation and the prevention of cardiovascular disease

  2007cited by this paper
• Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies: the fibrinogen studies collaboration.

  2007cited by this paper
• Fibrinogen and coronary heart disease: test of causality by 'Mendelian randomization'.

  2006cited by this paper
• Regression dilution methods for meta-analysis: assessing long-term variability in plasma fibrinogen among 27,247 adults in 15 prospective studies.

  2006cited by this paper
• Epidemiology: Study Design and Data Analysis (2nd ed.)

  2006influential reference
• Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC)

  2005cited by this paper
• Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.

  2005cited by this paper
• Circulating inflammatory markers and risks of cardiovascular and non‐cardiovascular disease

  2005cited by this paper
• Does Elevated Plasma Fibrinogen Increase the Risk of Coronary Heart Disease?: Evidence from a Meta-Analysis of Genetic Association Studies

  2005cited by this paper
• Predicting cardiovascular risk

  2005cited by this paper
• Extent of regression dilution for established and novel coronary risk factors: results from the British Regional Heart Study

  2004cited by this paper
• MONICA monograph and multimedia sourcebook: world's largest study of heart disease, stroke, risk factors, and population trends 1979-2002.

  2003cited by this paper
• Contribution of contemporaneous risk factors to social inequality in coronary heart disease and death: Scottish Heart Health Cohort Study

  2003cited by this paper
• Contribution of contemporaneous risk factors to social inequality in coronary heart disease and all causes mortality.

  2003cited by this paper
• Fibrinogen as a risk factor for coronary heart disease and mortality in middle-aged men and women. The Scottish Heart Health Study.

  1998cited by this paper
• Update on fibrinogen as a cardiovascular risk factor.

  1992cited by this paper
• Collaborative Study of a Proposed International Standard for Plasma Fibrinogen Measurement

  1992cited by this paper
• Cardiovascular disease risk profiles.

  1991cited by this paper
• Plasma fibrinogen and coronary risk factors: the Scottish Heart Health Study.

  1991cited by this paper
• Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study.

  1986cited by this paper
• Fibrinogen as a risk factor for stroke and myocardial infarction.

  1984cited by this paper
• The Minnesota code manual of electrocardiographic findings : standards and procedures for measurement and classification

  1982cited by this paper
• Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens

  1957cited by this paper
• [Rapid physiological coagulation method in determination of fibrinogen].

  1957cited by this paper

• Epidemiology, fibrinogen, clot properties, and cardiovascular disease risk—an African perspective

  2025cites this paper
• Associations of Hemostatic Variables with Cardiovascular Disease and Total Mortality: The Glasgow MONICA Study

  2022cites this paper
• Associations of Hemostatic Variables with Cardiovascular Disease and Total Mortality: The Glasgow MONICA Study

  2022cites this paper
• A Systematic Review and Meta-Analysis of Advanced Biomarkers for Predicting Incident Cardiovascular Disease among Asymptomatic Middle-Aged Adults

  2022cites this paper
• Biomarker association with cardiovascular disease and mortality - The role of fibrinogen. A report from the NHANES study.

  2020cites this paper
• Plasma and blood viscosity in the prediction of cardiovascular disease and mortality in the Scottish Heart Health Extended Cohort Study

  2017cites this paper
• Publications for Mark Woodward 2016

  2016cites this paper
• PM303 Can C-Reactive Protein and Fibrinogen Predict Major Adverse Cardiac Events in Cardiovascular and Cerebrovascular Patients?

  2016cites this paper
• Uloga fibrinogena u bolestima kardiovaskularnog sustava

  2016cites this paper
• Novel biomarkers for cardiovascular risk assessment: current status and future directions.

  2015cites this paper
• Strategies for treating lipids for prevention: risk stratification models with and without imaging.

  2014cites this paper
• A coronary heart disease prediction model: the Korean Heart Study

  2014cites this paper
• The relevance of coagulation in cardiovascular disease: what do the biomarkers tell us?

  2014influential citation
• Critical appraisal of inflammatory markers in cardiovascular risk stratification

  2014cites this paper
• For peer review only A coronary heart disease prediction model: the Korean Heart Study

  2014cites this paper
• Direct comparisons of three alternative plasma fibrinogen assays with the von Clauss assay in prediction of cardiovascular disease and all‐causes mortality: the Scottish Heart Health Extended Cohort

  2013cites this paper
• Cardiovascular risk prediction in Central and Eastern Europe and former Soviet Union

  2012cites this paper
• From circulating biomarkers to genomics and imaging in the prediction of cardiovascular events in the general population

  2012cites this paper
• Comparisons of established risk prediction models for cardiovascular disease: systematic review

  2012cites this paper
• Use of reclassification for assessment of improved prediction: an empirical evaluation.

  2011cites this paper
• Can haemostatic factors predict atherothrombosis?

  2011cites this paper
• The prognostic value of adipose tissue fatty acids for incident cardiovascular disease: results from 3944 subjects in the Scottish Heart Health Extended Cohort Study.

  2011cites this paper
• Cardiovascular Risk and Risk Scores: ASSIGN, Framingham, QRISK and others: how to choose

  2011cites this paper
• Fibrinogen assays for cardiovascular risk assessment.

  2010cites this paper
• Role of biomarkers in predicting CVD risk in the setting of HIV infection?

  2010cites this paper
• Effects of fibrinogen concentrate administration during severe hemorrhage

  2010cites this paper
• Criteria for scientific evaluation of novel markers: a perspective.

  2010cites this paper
• Aterosclerosis: biomarcadores plasmáticos emergentes

  2010cites this paper
• Sources of variation in factor VIII, von Willebrand factor and fibrinogen measurements: implications for detecting deficiencies and increased plasma levels.

  2010cites this paper